AIG
UBX

American International Group’s Unity Biotechnology UBX Stock Holding History

American International Group’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,065
Closed -$124 – 3273
2021
Q1 		$124 Buy
2,065
+5
+0.2% +$341 ﹤0.01% 2603
2020
Q4 		$108 Sell
2,060
-24
-1% -$1.16K ﹤0.01% 2620
2020
Q3 		$72K Buy
2,084
+71
+4% +$4.5K ﹤0.01% 2707
2020
Q2 		$175K Buy
2,013
+321
+19% +$23.8K ﹤0.01% 2199
2020
Q1 		$98K Sell
1,692
-97
-5% -$6.11K ﹤0.01% 2315
2019
Q4 		$129K Buy
1,789
+104
+6% +$7.34K ﹤0.01% 2477
2019
Q3 		$103K Sell
1,685
-12
-0.7% -$849 ﹤0.01% 2590
2019
Q2 		$161K Buy
1,697
+110
+7% +$9.36K ﹤0.01% 2371
2019
Q1 		$129K Sell
1,587
-52
-3% -$5.9K ﹤0.01% 2474
2018
Q4 		$266K Buy
1,639
+1,304
+389% +$173K ﹤0.01% 2022
2018
Q3 		$55K Buy
335
+6
+2% +$988 ﹤0.01% 3047
2018
Q2 		$50K Buy
+329
New +$48.1K ﹤0.01% 2991

Other funds holding UBX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

American International Group's UBX Position: Q2 2021 in Review

American International Group sold out of Unity Biotechnology (UBX) in Q2 2021, closing a stake of 2,065 shares — an estimated $124 sold.

American International Group first reported a position in UBX in Q2 2018 and held it in 12 quarters. The position peaked at $266K in Q4 2018. 98 funds tracked by Wall St. Rank hold UBX as of Q2 2021.

  • American International Group reported no remaining Unity Biotechnology position as of Q2 2021 after selling out during the quarter.
  • American International Group sold 2,065 Unity Biotechnology shares in Q2 2021, an estimated $124.
  • American International Group first reported a position in Unity Biotechnology in Q2 2018 and held it in 12 quarters.
  • American International Group's Unity Biotechnology position peaked at $266K in Q4 2018.
  • 98 funds tracked by Wall St. Rank held Unity Biotechnology as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.